BMED: BlackRock Future Health ETF
What this ETF is trying to do
The BlackRock Future Health ETF (BMED) is an exchange-traded fund (ETF) that focuses on the healthcare and health technology sectors. It aims to provide investors with exposure to companies involved in medical services, pharmaceuticals, and other health-related industries.
What the numbers show
The current price of BMED is $33.74. This is compared to an estimated price from roughly one year ago of $27.86.
To understand how this ETF has performed, it is helpful to look at two different types of measurements: price return and total return.
• One-Year Performance: The share-price return over the last year was approximately 21.11%. The total return for that same period was approximately 21.45%.
• Three-Year Performance: Over three years, the share-price return was approximately 50.46%, while the total return was approximately 50.94%.
• Five-Year Performance: The five-year total return is approximately 16.40%.
The price return only measures how much the share price changed. The total return includes those price changes plus any distributions (like cash payments) provided by the fund.
Income and distribution explanation
This ETF has a distribution yield of approximately 0.24%. In the last 12 months, there was one payout. These distributions happen on an irregular or less frequent basis. It is important for new investors to know that a high distribution yield does not automatically mean an investor earned that percentage as their total return.
NAV erosion explanation
StockValueFinder uses specific measurements to look for "NAV erosion." NAV erosion is a term used to describe when the value of the underlying assets in an ETF drops over time.
For this ETF, the erosion-risk score is 100, and the label states "No price erosion detected." Additionally, there is no severe erosion-risk flag for this fund. This means that based on StockValueFinder's screening rules, the fund did not show signs of substantial price deterioration or a weak erosion score.
Pros
• The ETF has shown positive share-price returns over one-year, three-year, and five-year periods.
• It provides exposure to a variety of large healthcare companies.
• No severe erosion-risk flag was detected.
Cons
• Distributions are irregular and occur less frequently.
• The distribution yield is relatively low compared to some other types of income-focused funds.
Portfolio Exposure
This list represents the Top Holdings (a partial list) as of October 7, 2026. These holdings can change over time: 1. JOHNSON & JOHNSON: 6.81% 2. AMGEN INC: 4.02% 3. EDWARDS LIFESCIENCES CORP: 4.01% 4. INTUITIVE SURGICAL INC: 3.99% 5. MERCK & CO INC: 3.94% 6. CENCORA INC: 3.74% 7. MCKESSON CORP: 3.71% 8. GILEAD SCIENCES INC: 3.27% 9. DANAHER CORP: 3.12% 10. IDEXX LABORATORIES INC: 3.03%
Beginner takeaway
The BlackRock Future Health ETF tracks the healthcare sector and has shown positive price returns over several years. While it provides a way to invest in health companies, its distributions are infrequent and have a low yield. This report is for educational purposes only and does not constitute financial advice.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | JOHNSON & JOHNSON | JNJ | 6.81% |
| 2 | AMGEN INC | AMGN | 4.02% |
| 3 | EDWARDS LIFESCIENCES CORP | EW | 4.01% |
| 4 | INTUITIVE SURGICAL INC | ISRG | 3.99% |
| 5 | MERCK & CO INC | MRK | 3.94% |
| 6 | CENCORA INC | COR | 3.74% |
| 7 | MCKESSON CORP | MCK | 3.71% |
| 8 | GILEAD SCIENCES INC | GILD | 3.27% |
| 9 | DANAHER CORP | DHR | 3.12% |
| 10 | IDEXX LABORATORIES INC | IDXX | 3.03% |